SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B3 - Prospectus [Rule 424(b)(3)]:
SEC Accession No. 0001140361-21-016825
Filing Date
2021-05-11
Accepted
2021-05-11 16:31:26
Documents
2

Document Format Files

Seq Description Document Type Size
1 424B3 nt10023650x3_424b3.htm 424B3 339377
2 logo_brooklyn.jpg GRAPHIC 97422
  Complete submission text file 0001140361-21-016825.txt   474681
Mailing Address 140 58TH STREET, BUILDING A SUITE 2100 BROOKLYN NY 11220
Business Address 140 58TH STREET, BUILDING A SUITE 2100 BROOKLYN NY 11220 (212) 582-1199
Brooklyn ImmunoTherapeutics, Inc. (Filer) CIK: 0000748592 (see all company filings)

IRS No.: 311103425 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B3 | Act: 33 | File No.: 333-255694 | Film No.: 21911748
SIC: 2834 Pharmaceutical Preparations